These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 22495291
1. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, Nasr SH, Fervenza FC, Cornell LD, Fidler ME, Dogan A. Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291 [Abstract] [Full Text] [Related]
2. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. Sethi S, Dasari S, Amin MS, Vrana JA, Theis JD, Alexander MP, Kurtin PJ. Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293 [Abstract] [Full Text] [Related]
3. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A. Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678 [Abstract] [Full Text] [Related]
4. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, Quint P, Leung N, Dogan A, Nasr SH. Clin J Am Soc Nephrol; 2013 Jun; 8(6):915-21. PubMed ID: 23411427 [Abstract] [Full Text] [Related]
6. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJ, Spinner RJ, Mauermann ML, Bergen HR, Zeldenrust SR, Dogan A. Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937 [Abstract] [Full Text] [Related]
7. Mass spectrometry based proteomics in the diagnosis of kidney disease. Sethi S, Vrana JA, Theis JD, Dogan A. Curr Opin Nephrol Hypertens; 2013 May; 22(3):273-80. PubMed ID: 23470817 [Abstract] [Full Text] [Related]
8. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Nasr SH, Said SM, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Dispenzieri A, Buadi FK, Vrana JA, Theis JD, Dogan A, Leung N. Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715 [Abstract] [Full Text] [Related]
9. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies. Bindi G, Smith A, Oliveira G, Eccher A, Vatrano S, Alberici F, Cazzaniga G, Galimberti S, Capitoli G, Magni F, Pagni F, L'Imperio V. J Clin Pathol; 2024 May 17; 77(6):402-410. PubMed ID: 36813560 [Abstract] [Full Text] [Related]
10. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. Gilbertson JA, Theis JD, Vrana JA, Lachmann H, Wechalekar A, Whelan C, Hawkins PN, Dogan A, Gillmore JD. J Clin Pathol; 2015 Apr 17; 68(4):314-7. PubMed ID: 25637636 [Abstract] [Full Text] [Related]
11. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics. Li Y, Zhang Y, Zhou X, Xue X, Wang M, Kang D, Zhou Y, Hu R, Quan S, Xing G, Yang J. BMC Nephrol; 2023 Mar 10; 24(1):50. PubMed ID: 36894904 [Abstract] [Full Text] [Related]
12. Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition. Li D, Liu D, Xu H, Yu XJ, Zhou FD, Zhao MH, Wang SX. BMC Nephrol; 2019 Dec 23; 20(1):476. PubMed ID: 31870425 [Abstract] [Full Text] [Related]
13. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis. Aoki M, Kang D, Katayama A, Kuwahara N, Nagasaka S, Endo Y, Terasaki M, Kunugi S, Terasaki Y, Shimizu A. Clin Exp Nephrol; 2018 Aug 23; 22(4):871-880. PubMed ID: 29372474 [Abstract] [Full Text] [Related]
14. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry. Gonzalez Suarez ML, Zhang P, Nasr SH, Sathick IJ, Kittanamongkolchai W, Kurtin PJ, Alexander MP, Cornell LD, Fidler ME, Grande JP, Herrera Hernandez LP, Said SM, Sethi S, Dispenzieri A, Gertz MA, Leung N. Kidney Int; 2019 Oct 23; 96(4):1005-1009. PubMed ID: 31447055 [Abstract] [Full Text] [Related]
15. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis. Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, Nasr SH. Nephrol Dial Transplant; 2015 Jul 23; 30(7):1151-5. PubMed ID: 25796445 [Abstract] [Full Text] [Related]
16. Renal amyloidosis associated with a novel sequence variant of gelsolin. Sethi S, Theis JD, Quint P, Maierhofer W, Kurtin PJ, Dogan A, Highsmith EW. Am J Kidney Dis; 2013 Jan 23; 61(1):161-6. PubMed ID: 22938848 [Abstract] [Full Text] [Related]
18. [Proteomics, a new tool for an accurate typing of amyloidosis]. Colombat M, Holifanjaniaina S, Onifarasoaniaina S, Valleix S, Maisonneuve H, Kahn JE, plateforme protéomique de l'université Paris Descartes (3P5). Rev Med Interne; 2015 May 23; 36(5):346-51. PubMed ID: 25544147 [Abstract] [Full Text] [Related]